Our FORUM programme convenes participants across sectors for national discussions on scientific opportunities, technology trends and developments for health and life sciences.
➡️ Discover how your organisation can join FORUM: bit.ly/4tlITKy
Professor Paul Freemont next to a quote that reads: "This is a fantastic opportunity to learn about the rapid advances in engineering biology applied to healthcare. With the rapid convergence of AI, automation and biomedical sciences, we are at a tipping point of opportunity and discovery that will provide new therapies and knowledge on disease mechanisms. "
Join us in Scotland for our FORUM Sir Colin Dollery Lecture ✨
📅 Tues 2 June
📍 Edinburgh
This year's keynote lecture delivered by Prof Susan Rosser FRSE FLSW will explore the power of engineering biology to improve health and tackle key challenges.
➡️ bit.ly/4cuF52d
Academy Professorship Scheme awardee, Professor Philip Shaw, next to a quote that reads: "Be bold, come up with your best idea, event if it's a seed - put it forward and build on it ambitiously."
The scheme is helping Professor Philip Shaw deepen his research into the progression of ADHD, turning new insights into more targeted treatments and interventions.
See how the programme is supporting his work and his advice for applying.
🔒 www.researchprofessionalnews.com/rr-funding-i...
Are you a biomedical or healthcare researcher who has recently moved to the UK to start a full Professorship?
You could receive up to £500k to power your research through our Professorship scheme 🚀
🗓️ Apply by Wed 10 June 2026
➡️ bit.ly/4tfc9Td
We’re excited to get going with our Commercialising Cell & Gene Therapies event to mark the launch of the @acmedsci.bsky.social North of England Cross-Sector Hub here at @newcastleuni.bsky.social Frederick Douglass Centre.
Springboard awardee Dr Jan Vollert next to a quote that reads: "This is a step change in my career trajectory, one that hopefully will lead to better pain prevention and treatment in the UK."
With support from the Department of Science, Innovation and Technology, @wellcometrust.bsky.social and @thebhf.bsky.social, this year’s funded projects will also help strengthen the UK’s ability to prevent and respond to future health emergencies.
Springboard awardee Dr Amy Lloyd next to a quote that reads: "The Springboard award will enable me to address critical, yet underexplored questions surrounding women’s health in neurodegenerative diseases."
These awards support researchers at a critical stage in their careers, giving them the freedom to test ambitious ideas and tackle some of today's most pressing health challenges - from Parkinson’s and Alzheimer’s to infectious disease and chronic pain 🧠🧬
Springboard awardee Dr Rodrigo Vitorio next to a quote that reads: "The Springboard support will enable me to take a crucial next step in understanding how tDCS can be optimised and personalised for people with Parkinson's."
We’re pleased to share the latest round of our Springboard programme 👏
This year we're supporting 55 early career researchers across the UK whose bold ideas have the potential to save lives, by investing £6.7M in discovery-driven health research 💡
➡️ bit.ly/4syNGa8
Are you a researcher, clinician, cell and gene therapy industry partner, or innovation ecosystem stakeholder?
Join us next week in Newcastle for the launch event for the @acmedsci.bsky.social North of England Cross-Sector Hub launch
www.thenhsa.co.uk/events/comme...
1 /2
We are delighted to announce that Prof Mimoun Azzouz will be delivering the opening keynote for the launch event of @acmedsci.bsky.social North of England cross-sector hub - Commercialising Cell & Gene Therapies: From Idea to Patient Impact, hosted by the NHSA.
www.eventbrite.co.uk/e/commercial...
A strong life sciences sector benefits patient lives and can improve economic growth through investment and skilled jobs.
But for patients to feel the full benefit, this must go hand in hand with broader investment in the NHS and the health and care services they rely on.
We're encouraged by:
✅ The commitment to increase spending on innovative medicines, backed by interim targets
✅Changes to how NICE measures the impact of treatments on patients’ quality of life, bringing its methods in line with latest evidence
President of the Academy, Professor Andrew Morris, next to a quote that reads: "Getting effective treatments to patients faster is what matters most, and the approval of new medicines as a direct result of these changes shows that this arrangement can make a real difference to people and families."
The approval of new medicines under the UK Govt's pharmaceutical partnership with the US can make a real difference to people and families by getting effective treatments to patients faster.
Read today's announcement: ow.ly/QVOR50YCpXo
And scroll for our full reaction 🧵
The SUSTAIN scheme is still open for applications until 8 April. This programme supports women in research to develop leadership and career potential, and is open to award-holders from eligible Royal Society, @raeng.org.uk and @acmedsci.bsky.social schemes. https://royalsociety.org/grants/sustain/
Research led by Academy of Medical Sciences Professorship awardee Juanma Vaquerizas on the front cover of Nature Genetics – great to see this work gaining global attention
The professorship scheme is funded by the Department for Science, Innovation and Technology.
Are you a researcher, clinician, cell and gene therapy industry partner, or innovation ecosystem stakeholder?
Join us for @acmedsci.bsky.social’s North of England Cross-Sector Hub launch event - Commercialising Cell and Gene Therapies: From Idea to Patient Impact
www.thenhsa.co.uk/events/comme...
A person wearing glasses is smiling slightly, with a blurred outdoor background. Text beside them reads: "SUSTAIN offered a guided self-reflection I didn't realize I needed. Discussing growth alongside women as powerful yet vulnerable as myself was transformative." Below, it says, "Dr. Gülşen Sürmeli, Sir Henry Dale Fellow, University of Edinburgh." The Royal Society logo is at the bottom.
We and @acmedsci.bsky.social have announced a new partnership to develop the next generation of female research leaders through an expansion of the SUSTAIN programme, doubling the number of places for Royal Society-funded researchers. Find out more:
#RSGrants
royalsociety.org/news/2026/03...
Text that reads "celebrating Springboard, 10 years" on a navy blue background
We're celebrating 10 years of Springboard 🎉
Over the past decade, the programme has supported 400+ early career researchers across the UK, turning discovery science into real‑world health benefits 🔬✨
Meet the researchers behind Springboard: bit.ly/4sDdLW1
#BritishScienceWeek #Springboard
🎟️Commercialising Cell and Gene Therapies: From Idea to Patient Impact 🎟️
We are excited to announce the first in a series of events, hosted by the NHSA, marking the launch of the @acmedsci.bsky.social North of England Cross-Sector Hub.
Book your space: www.eventbrite.com/e/commercial...
Dr Tan Chorh Chuan FMedSci is Permanent Secretary (National Research and Development) in the Prime Minister’s Office, Singapore 🏥 A renal physician and former Director of Medical Services, he is internationally recognised for his leadership in public health and science policy.
Dr John Climax FMedSci is a biotechnology leader and co-founder of ICON plc, a leading clinical research organisation 🔬 He is also Founder and CEO of Afimmune, developing new medicines for rare diseases, and founded the Human Dignity Foundation to protect children's rights.
Dr Kiran Mazumdar-Shaw FMedSci is the founder and Executive Chairperson of Biocon, a leading biopharmaceutical company based in India 💊 A pioneer of India’s biotechnology sector, she has led major advances in affordable biologics for cancer, diabetes and autoimmune diseases.
Congratulations to our new Honorary Fellows who have been elected for their outstanding contributions across health and science, driving innovation and improving lives around the world 🎉 Read more: bit.ly/4czLnPL And scroll to learn about our new Honorary Fellows
Dr Kiran Mazumdar-Shaw FMedSci is the founder and Executive Chairperson of Biocon, a leading biopharmaceutical company based in India 💊
A pioneer of India’s biotechnology sector, she has led major advances in affordable biologics for cancer, diabetes and autoimmune diseases.
Dr Roxanne Keynejad, former Starter Grant awardee, next to a quote that reads: "My Starter Grant has provided vital bridging funds to strengthen my research partnerships and collaboratively develop post-doctoral funding proposals."
Calling early-career clinical lecturers across medicine, dentistry and veterinary medicine 📢
Are you looking to kickstart your career? Apply for an Academy Starter Grant to receive up to £40k in funding (up from £30k!)
🗓️ Apply by Thurs 26 Feb
👉 bit.ly/466Zvw6
Developed in partnership with six national academies across Africa, Asia and Latin America, the report sets out clear recommendations to help strengthen the clinical research workforce in LMICs 💡🤝
Read more: bit.ly/3MmST5T
LMICs carry some of the highest health burdens and mortality, standing to gain the most from the benefits of health research 🌍🔬
But across many LMICs, the lack of formalised career pathways creates significant barriers for young researchers to enter and progress 🥼
Professor Shakila Thangaratinam FMedSci, Vice President (International) at the Academy of Medical Sciences, next to a quote that reads: "Investment in clinical research is an economic and public health necessity but talented researchers can only thrive when the system is in place to support them."
Our latest report highlights the urgent need for stronger support for clinical researchers in low- and middle-income countries (LMICs) 🌍🥼
Read the report: bit.ly/45ZMswm
Scroll to learn more 🧵
@thangaratinam.bsky.social
Dr Bahijja Raima-Abraham, Cross-Sector Experience Awardee, next to a quote that reads: "Cross-sector collaboration is essential to life sciences. It unites diverse expertise to create impactful solutions to global health challenges."
Two weeks left ⌛
Apply for our Cross-Sector Experience Awards to improve human health through collaboration
💷 Receive up to 100K in funding
🤝 Work up to 1 year in a new sector
📃 Open to UK-based applicants from any sector
Apply by 20 Feb 2026: https://bit.ly/3ZTeXYY
Four images from the Academy's CATAC 2025 event featuring people speaking at a lectern, asking questions from the audience and presenting to a small group.
Registration is open for CATAC 2026 🎉
A great opportunity for early-career researchers in medicine or health to learn from clinical academics and grow your network 🤝
🗓️ Wed 29 April
📍 MRC Laboratory of Medical Sciences, London
➡️ Register now: bit.ly/4aszpWM
@mrc-lms.bsky.social